Treatment decisions in end-stage COPD: who decides how? A cross-sectional survey of different medical specialties

Martin Gäbler, Gerald Ohrenberger, Georg-Christian Funk

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Artikel in Fachzeitschrift

3 Zitate (Scopus)

Abstract

INTRODUCTION: End-stage chronic obstructive pulmonary disease (COPD) patients with acute respiratory failure are often treated by representatives from different medical specialties. This study investigates if the choice of treatment is influenced by the medical specialty.

METHODS: An online cross-sectional survey among four Austrian medical societies was performed, accompanied by a case vignette of a geriatric end-stage COPD patient with acute respiratory failure. Respondents had to choose between noninvasive ventilation (NIV), a conservative treatment attempt (without NIV) and a palliative approach. Ethical considerations and their impact on decision making were also assessed.

RESULTS: Responses of 162 physicians (67 from intensive care units (ICUs), 51 from pulmonology or internal departments and 44 from geriatric or palliative care) were included. The decision for NIV (instead of a conservative or palliative approach) was associated with working in an ICU (OR 14.9, 95% CI 1.87-118.8) and in a pulmonology or internal department (OR 9.4, 95% CI 1.14-78.42) compared with working in geriatric or palliative care (Model 1). The decision for palliative care was negatively associated with working in a pulmonology or internal department (OR 0.16, 95% CI 0.05-0.47) and (nonsignificantly) in an ICU (OR 0.41, 95% CI 0.15-1.12) (Model 2).

CONCLUSIONS: Department association was shown to be an independent predictor for treatment decisions in end-stage COPD with acute respiratory failure. Further research on these differences and influential factors is necessary.

OriginalspracheEnglisch
Aufsatznummer00163-2018
FachzeitschriftERJ Open Research
Jahrgang5
Ausgabenummer3
DOIs
PublikationsstatusVeröffentlicht - 01 Juli 2019

Fingerprint

Untersuchen Sie die Forschungsthemen von „Treatment decisions in end-stage COPD: who decides how? A cross-sectional survey of different medical specialties“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren